Goldman Sachs
ISLEW

Goldman Sachs’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Goldman Sachs’s Portfolio ISLEW Stock Details ISLEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-75,452
Closed -$2K – 6813
2022
Q2 		$2K Sell
75,452
-455
-0.6% -$58 ﹤0.01% 6406
2022
Q1 		$13K Buy
75,907
+455
+0.6% +$151 ﹤0.01% 6461
2021
Q4 		$38K Hold
75,452
– – ﹤0.01% 6306
2021
Q3 		$41K Hold
75,452
– – ﹤0.01% 6086
2021
Q2 		$53K Sell
75,452
-168,154
-69% -$99.4K ﹤0.01% 6062
2021
Q1 		$114K Buy
+243,606
New +$117K ﹤0.01% 5805

Goldman Sachs's ISLEW Position: Q3 2022 in Review

Goldman Sachs sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q3 2022, closing a stake of 75,452 shares — an estimated $2K sold.

Goldman Sachs first reported a position in ISLEW in Q1 2021 and held it in 6 quarters. The position peaked at $114K in Q1 2021. 0 funds tracked by Wall St. Rank hold ISLEW as of Q3 2022.

  • Goldman Sachs reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 75,452 Isleworth Healthcare Acquisition Corporation Warrant shares in Q3 2022, an estimated $2K.
  • Goldman Sachs first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
  • Goldman Sachs's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $114K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.